How much funding has TreeFrog Therapeutics raised?

TreeFrog Therapeutics has raised $75.0M in total funding, most recently a Series B round.

Where is TreeFrog Therapeutics headquartered?

TreeFrog Therapeutics is headquartered in Bordeaux, France.

What industry is TreeFrog Therapeutics in?

TreeFrog Therapeutics operates in Biotech, Cell Therapy.

TreeFrog Therapeutics

Cell therapy for all

Bordeaux, France · $75.0M raised

Biotech

Cell Therapy

Headquarters: Bordeaux
Website: treefrog.fr
Total Funding: $75.0M

Last Round: $75.0M Series BApr 2021
Rounds: 1

About

TreeFrog Therapeutics is a clinical-stage biotech company pioneering scalable manufacturing of iPS-derived cell therapies through its proprietary C-Stem™ technology platform. The C-Stem™ system uses biomimetic encapsulation to generate over 1,000 capsules per second in GMP-compliant conditions, enabling production of 15 billion cells per batch in bioreactors up to 10 liters — unlocking commercial-scale manufacturing previously unachievable in cell therapy. The company's lead program targets Parkinson's Disease, with a first-in-human trial planned by 2026, alongside discovery programs for liver disease. TreeFrog also out-licenses the C-Stem™ platform to pharmaceutical partners. Founded in 2018 in Bordeaux, France, the company has raised $82 million, employs over 130 people, and holds 30 patent families protecting its stem cell innovations.

Summary

TreeFrog Therapeutics is a Biotech company based in Bordeaux, France. It has raised $75.0M in total across 1 round, most recently a $75.0M Series B round in Apr 2021.